Background: Studies reporting outcomes following staged/synchronous carotid revascularisation prior to cardiac surgery have generally concluded that procedural strokes are reduced. However, virtually none have commented specifically on the risk of stroke in patients with bilateral carotid disease who then undergo their cardiac procedure in the presence of an unoperated, contralateral stenosis. If carotid disease really was an important cause of perioperative stroke, these patients should incur a much higher risk of stroke following their cardiac procedure. Methods: Retrospective audit of prospectively acquired data in 132 consecutive patients undergoing synchronous carotid endarterectomy and cardiac surgery. Results: Overall 30-day rates of mortality, ipsilateral stroke and any stroke were 5.3%, 1.5% and 3% respectively. The 30-day rate of death/stroke was 6.8%. In 51 patients with a prior history of stroke/TIA, the 30-day rate of death/stroke was 5.9%, compared with 7.4% in neurologically asymptomatic patients. The majority (57%) had significant bilateral disease and underwent their combined procedure in the presence of a significant, non-operated (asymptomatic) contralateral stenosis (50e99% Z 75, 60e99% Z 54, 70e99% Z 32). Only one patient (90e99% stenosis) suffered a post-operative stroke in the hemisphere ipsilateral to the nonoperated, contralateral stenosis. Conclusions: Patients undergoing synchronous procedures incurred a low rate of procedural stroke, perhaps justifying this management approach. However, an alternative and more critical analysis suggested that the risk of procedural stroke in patients with significant (non-operated) contralateral asymptomatic carotid disease was extremely low. This challenges the assumption that asymptomatic carotid disease is an important cause of stroke during cardiac surgery. ª
Introduction
The management of patients undergoing cardiac surgery in the presence of significant carotid disease is an enduringly controversial subject, often attracting totally polarised interpretations of the same literature. 1e5 One of the most controversial issues is whether asymptomatic carotid disease is an important aetiological factor in stroke after cardiac surgery, or simply a marker of increased risk. 2, 6, 7 The aim of the current study was to analyse the outcomes of a series of patients undergoing synchronous carotid and cardiac revascularisation, both conventionally, and then in an alternative manner in order to determine the risk of stroke in patients with bilateral carotid disease who then underwent a unilateral carotid endarterectomy plus cardiac procedure in the presence of an unoperated, contralateral significant stenosis. If carotid disease really was an important cause of post-operative stroke, these patients should incur a much higher risk of stroke. If the risk of stroke was found to be low, this would cast significant doubt upon the rationale for offering staged or synchronous interventions in neurologically asymptomatic patients undergoing cardiac surgery.
Materials and Methods
A retrospective review was undertaken of prospectively audited outcome data regarding 30-day morbidity and mortality in 132 consecutive patients undergoing synchronous carotid endarterectomy (CEA) and cardiac surgery between March 1995 and December 2009. All of the carotid procedures were performed by one vascular surgeon. The Leicestershire, Northamptonshire and Rutland Research Ethics Committee advised that this study did not fall under the remit of the NHS Research Ethics Committee as it was audit/service evaluation.
Case selection
The study cohort was primarily derived from patients undergoing cardiac surgery at the Glenfield Hospital, Leicester who were found (during pre-assessment) to have significant carotid disease. Unit policy required that cardiac surgery patients who; (i) reported a prior history of stroke or transient ischaemic attack (TIA), or (ii) had an audible carotid bruit, or (iii) were found to have significant left mainstem disease following coronary angiography should undergo a pre-operative Duplex ultrasound scan. This evaluated the extracranial carotid arteries, as well as flow in the subclavian and extracranial vertebral arteries. It is, therefore, accepted that an indeterminate number of patients who were not screened (pre-operatively) by ultrasound may have undergone their cardiac surgery in the presence of a significant, asymptomatic carotid stenosis. A much smaller cohort of patients (7/132) presented with a history of very recent onset carotid territory symptoms and were considered to be too high risk to undergo isolated CEA because of severe cardiac disease. None of the latter patients were suitable for coronary artery stenting. The term 'neurologically asymptomatic' refers to any patient who did not report a prior history of carotid or vertebrobasilar territory events. The term 'neurologically symptomatic' refers to any patient who reported a history of stroke or TIA in the carotid or vertebrobasilar territories at any time in the past. It was not possible to reliably determine whether previous neurological symptoms were attributable to significant carotid disease as some of the events could have happened some years earlier.
Prior to January 2004, cardiac surgery patients who had significant unilateral or bilateral carotid disease (defined as a unilateral (NASCET derived) 70e99% stenosis, bilateral 70e99% stenoses or a unilateral 70e99% stenosis plus contralateral occlusion) underwent synchronous cardiac and carotid revascularisation, irrespective of whether the patient was neurologically asymptomatic or symptomatic. The carotid artery supplying the dominant hemisphere was preferentially reconstructed in neurologically asymptomatic patients with bilateral 70e99% stenoses, even if the contralateral carotid artery had the more severe stenosis.
Following a series of systematic reviews of the published literature in December 2003, 8e10 it was decided that management guidelines would remain the same except that patients with an asymptomatic, unilateral 70e99% carotid stenosis would not now undergo prophylactic CEA. The risks of procedural stroke in patients with a unilateral asymptomatic 70e99% stenosis undergoing isolated CABG since January 2004 have been published elsewhere. 7
Procedure
Carotid endarterectomy was performed immediately prior to median sternotomy. The carotid bifurcation was exposed via an anterior sternomastoid incision. Prior to carotid clamping, all patients received an intravenous dose of 5000 IU of unfractionated heparin. A standard endarterectomy was performed using routine shunting (Pruitt-Inahara), routine tacking of the proximal and distal intimal steps (7:0 Prolene), with closure of the arteriotomy with a vein patch harvested from the long saphenous vein in the groin. Following completion of the carotid procedure, haemostasis was checked and secured and the wound temporarily closed pending formal closure after completion of the cardiac procedure. This was in order to minimise the risks of neck haematoma formation during the cardiac procedure when high dose heparin was administered.
A variety of cardiac procedures were performed in this series ( Table 1 ) and all were performed with the patient on cardiopulmonary bypass. No cardiac procedure in this series was performed using either minimally invasive direct coronary artery bypass grafting or offpump coronary artery bypass grafting. Post-operatively, patients were nursed in the Cardiac Surgery Intensive Care Unit prior to transfer back to the cardiac surgery ward for ongoing care. Following hospital discharge, patients returned for clinical review by both the cardiac and vascular surgeons. For the purposes of this study, primary endpoints were; (i) death, (ii) any stroke and (iii) ipsilateral stroke within 30 days of surgery. A stroke was defined as any new focal neurological deficit (or any worsening of a pre-existing focal neurological deficit) or coma that had not recovered fully within 24 h. Any patient suffering a stroke in the peri-operative period underwent a CT scan and/or autopsy to determine the likely cause. Secondary endpoints included 30-day rates of; (i) death/ipsilateral stroke and (ii) death/any stroke.
Results
Between March 1995 and January 2010, 132 consecutive patients underwent a synchronous cardiac and carotid procedure where the carotid operations were performed by the same vascular surgeon. Table 1 details the various cardiac procedures undertaken in this series; 100 patients underwent a primary coronary artery bypass graft (CABG). Thirty-two patients underwent some other type of cardiac procedure including; (i) CABG plus either valve replacement or left ventricular aneurysm repair (n Z 24), (ii) redo CABG (n Z 4), (iii) redo aortic or mitral valve replacement (n Z 4) and (iv) primary aortic valve replacement (n Z 1). Table 2 details the 30-day risks of death, any territory stroke, ipsilateral stroke and the cumulative endpoints of death/ipsilateral stroke and death/any stroke for the entire patient cohort and for selected subgroups. The 30day risk of death was 5.3% (n Z 7). The 30-day risk of ipsilateral stroke was 1.5% (n Z 2), while the 30-day risk of 'any stroke' was 3.0% (n Z 4). The 30-day risk of death/ ipsilateral stroke was 6.1% (n Z 8), while the risk of death/ any stroke was 6.8% (n Z 9). There was no significant difference in any 30-day outcome when stratified for; (i) gender, (ii) age, (iii) neurological symptom status, (iv) severity/bilateral nature of the carotid disease and (v) whether the cardiac procedure involved a primary CABG or more complex intervention.
There were four post-operative strokes in this series. Two were fatal; one following an ipsilateral intracranial haemorrhage on day 6, the second patient never recovered consciousness and died on day three following bilateral carotid and vertebrobasilar territory ischaemic infarctions (presumed secondary to atheroembolism from the aortic arch). The third stroke (ischaemic, presumed embolic) was ipsilateral to the operated CEA (normal carotid artery on Duplex ultrasound). The fourth stroke was again ischaemic and was contralateral to a non-operated 90%, previously asymptomatic stenosis. Duplex imaging after the stroke showed that the carotid artery was now occluded. Table 3 presents the outcome data stratified for preoperative neurological symptom status and extent of carotid disease. The procedural risks were relatively similar in patients who were either neurologically asymptomatic or symptomatic and the risks did not increase significantly in patients with severe bilateral carotid stenoses or contralateral occlusion. The 30-day risk of death/any stroke was 8.1% in neurologically asymptomatic patients with a unilateral 70e99% stenosis, 6.9% in asymptomatic patients with bilateral 70e99% stenoses and 6.7% in asymptomatic patients with a 70e99% stenosis and a contralateral occlusion. Parallel data for previously neurologically symptomatic patients were 3.7%, 9.7% and 9.1% respectively. 
No patient underwent bilateral CEAs in this series, but a significant proportion underwent combined surgery in the presence of bilateral carotid disease. Seventy-five patients (57%) underwent a combined procedure in the presence of a non-operated, contralateral asymptomatic 50e99% stenosis and only one of these patients (1.3%) suffered a stroke in the hemisphere ipsilateral to the non-operated, contralateral stenosis (patient had a 90% stenosis preoperatively). Fifty-four patients (41%) underwent a combined procedure in the presence of an asymptomatic non-operated, contralateral 60e99% stenosis; only one (1.9%) suffered a stroke ipsilateral to the non-operated stenosis. Finally, 42 patients (32%) had bilateral, severe (70e99%) stenoses at the time of undergoing their combined procedure. One reported a prior history of bilateral carotid territory symptoms. Accordingly, 41 patients underwent a combined procedure in the presence of a severe, asymptomatic (non-operated) contralateral stenosis. Only one of these patients (2.4%) suffered a stroke ipsilateral to the non-operated 70e99% stenosis (70e79% stenosis, n Z 21, no ipsilateral strokes; 80e89% stenosis, n Z 10, no ipsilateral strokes; 90e99% stenosis, n Z 10, one ipsilateral stroke). Table 4 details the causes of death in this study. Five of 81 neurologically asymptomatic patients died within 30 days (6.2%), but only one was stroke related. This patient died on day three having never recovered from anaesthesia. He had CT scan evidence of infarction in both carotid and both vertebrobasilar territories and it is assumed that this was an atheroembolic stroke originating from the aortic arch. The four other deaths in neurologically asymptomatic patients were either cardiac in origin (n Z 3) or followed multi-organ failure (n Z 1). Of these, one patient undergoing a redo, redo CABG went into acute left ventricular failure during the carotid procedure and required insertion of an intra-aortic balloon pump prior to undergoing his third CABG. He died of acute heart failure on the operating table immediately following completion of the cardiac procedure. The two other deaths in neurologically asymptomatic patients followed a cardiac arrest and acute myocardial infarction respectively.
Two of 51 patients reporting a prior history of stroke died in the first 30 days (3.9%). One followed acute onset cardiac failure 6 h post-operatively, while the second followed an intracranial haemorrhage on day 6.
Discussion
The management of patients with combined carotid and cardiac disease is enduringly controversial. 1e5 For many, the classical questions about whether CEA should be staged, reverse staged or synchronous 9, 10 or if aortic atheroembolism is the principle cause of peri-operative stroke 3 have been overtaken by more contemporary debates about whether carotid artery stenting (CAS) is the safer and preferred alternative. 11 However, while each camp (CEA/CAS) has its advocates and detractors, neither usually questions whether prophylactic carotid revascularisation actually benefits the majority of cardiac surgery patients. At first sight, the results in this series seem supportive of a policy of performing synchronous carotid and cardiac interventions. Out of a cohort of 132 patients, only two (1.5%) suffered an ipsilateral stroke following cardiac surgery, while only four (3.0%) suffered a stroke in 'any' vascular territory. Secondary endpoints included a 30day rate of death/ipsilateral stroke of 6.1% and a 30-day risk of death/any stroke of 6.8%. These results, therefore, compare very favourably with parallel data from systematic reviews and meta-analyses 9,10 (including those reporting CAS outcomes 11 ) and are well within the procedural risk guidelines set by the American Heart Association. 12 However, it sometimes pays to look beyond the headlines. The primary (only) reason for performing a staged or synchronous carotid revascularisation prior to cardiac surgery is to prevent procedural stroke. The prevention of 'late' stroke should not be considered to be a bona fide indication for prophylactic intervention in this situation; this is a bonus. Accordingly, it is important to first differentiate between symptomatic and asymptomatic patients when trying to determine the optimum management strategy.
There is a paucity of good quality natural history data regarding the risk of stroke after isolated cardiac surgery in patients who report a prior history of TIA or stroke and who are also found to have a significant carotid disease. This is partly because relatively few patients do not then undergo either staged or synchronous carotid revascularisation, but also because systematic reviews suggest that patients with a documented history of prior stroke/TIA face an almost fourfold excess risk of procedural stroke (Odds Ratio 3.6 (95%CI 2.7e4.9)), while patients with a ">50%" carotid stenosis incur a greater than fourfold excess risk of stroke after cardiac surgery (Odds Ratio 4.3 (95%CI 3.2e5.7) ). 8 In one of the few studies published to date, D' Agostino observed that the risk of stroke was 18% (5/28) in symptomatic patients with a unilateral carotid stenosis undergoing isolated cardiac surgery, increasing to 26% (5/19) in symptomatic patients with severe bilateral disease. 13 This compares with a <2% risk of stroke in neurologically asymptomatic patients with no significant carotid disease undergoing cardiac surgery. 8 Accordingly, it would be hard to criticise anyone who offered staged or synchronous CEA/ CAS to a neurologically symptomatic patient prior to undergoing cardiac surgery, especially in the current era of intervening as soon as possible after the index event in symptomatic patients. 14 But what about the neurologically asymptomatic patient? During the course of a five year audit in the USA (2000e2004), 27,084 patients underwent staged or synchronous procedures. 15 The overall in-hospital stroke/death rate was 6.9% (CAS), compared with 8.6% where CEA was performed (p Z 0.1). However, 97% of these procedures were undertaken in neurologically asymptomatic patients and this fact, alone, would suggest that a large body of opinion (and presumably evidence) must exist to support prophylactic CEA or CAS in this type of patient and that the procedural risks are significantly less than those found in patients undergoing isolated cardiac surgery?. As will be seen, the latter assumption may be open to question.
In the current series, neurologically asymptomatic patients undergoing a combined procedure incurred a 7.4% risk of death/any stroke at 30 days. This compares with a 5.1% risk reported in a systematic review of 16 studies where individual units stratified outcomes for both symptomatic and asymptomatic patients 10 and 9.1% in a systematic review of staged CAS þ CABG. In the latter study, 87% of patients were neurologically asymptomatic and 82% had unilateral disease. 11 The key question, however, is whether a 30-day risk of death/stroke of somewhere between 5 and 9% is significantly less than the risk facing a patient should he/she not undergo prophylactic carotid revascularisation.
The 30-day risk of death/stroke in the current series did not really correlate with the extent of carotid disease in asymptomatic patients (Table 3) , ranging from 8.1% (unilateral 70e99% stenosis) to 6.9% (bilateral 70e99% stenosis) and 6.7% (70e99% stenosis plus contralateral occlusion). In January 2004, practice changed in Leicester whereby patients with a unilateral, asymptomatic 70e99% stenosis did not thereafter undergo a prophylactic CEA. A five year audit of outcomes in 61 patients with unilateral, asymptomatic 70e99% stenoses who underwent isolated CABG between 2004 and 2009 7 found that not one patient suffered a stroke within 30 days of their cardiac operation, although three died (all following cardiac events). Although compared against historical controls, one cannot completely ignore the fact that the 30-day risk of death stroke following synchronous procedures in patients with unilateral, asymptomatic carotid stenoses performed between 1995 and 2009 (8.1%) was almost twice as high as the 30-day risk of death/stroke in similar patients who underwent isolated cardiac surgery between 2004 and 2009 (4.9% 7 ).
Leicester is not the only group to have reported extremely low procedural stroke risks in asymptomatic patients undergoing isolated cardiac surgery. Ghosh et al. 6 have also reported that not one out of 50 patients with 70e99% asymptomatic carotid stenoses (unilateral Z 20, bilateral Z 30) suffered a stroke following isolated cardiac surgery (30-day death/stroke rate was 4%). On a similar theme, Li has reported that 51 patients with an asymptomatic 70e99% stenosis (80e99% in 16) underwent isolated CABG procedures without incurring any strokes in the postoperative period and that 95% of all strokes occurring after cardiac surgery could not be attributed to carotid disease. 2 These three studies challenge the prevailing viewpoint that the presence of an asymptomatic carotid stenosis significantly increases the risk of stroke in cardiac surgery patients. If true, the rationale for performing staged or synchronous carotid revascularisations becomes flawed. The case against implementing an uncritical policy of prophylactic carotid revascularisation in neurologically asymptomatic patients undergoing cardiac surgery is also supported by new data from the current study.
If carotid disease was such an important cause of stroke after cardiac surgery, one would intuitively expect that there should be an increased risk of stroke in the hemisphere ipsilateral to an unoperated severe stenosis in patients presenting with bilateral disease. That, of course, is exactly the same rationale used by many surgeons and interventionists for undertaking staged or synchronous interventions in patients with unilateral carotid disease. But what about the patient with bilateral disease?. Only one of these arteries is reconstructed during staged/ synchronous procedures, leaving the other artery to be potentially responsible for causing procedural strokes. In the current study, more than half of the study cohort (57%) underwent their cardiac procedure in the presence of an unoperated, contralateral 50e99% stenosis; 41% had a 60e99% stenosis, while 32% had an unoperated 70e99% stenosis. However, only one of these patients suffered a stroke in the hemisphere ipsilateral to the non-operated stenosis (this patient had a 90% asymptomatic stenosis preoperatively). Overall, the risk of stroke in the non-operated hemisphere of 41 patients with contralateral 70e99% stenoses was 2.4%. If one now includes the 26 additional patients with contralateral occlusion (none of whom suffered a stroke in the hemisphere ipsilateral to the occlusion), only 1/101 patients with a 50e100% contralateral, stenosis suffered a post-operative stroke in the hemisphere ipsilateral to the non-operated ICA, compared with 1/80 with 60e100% stenoses and 1/67 with 70e100% stenoses. These data (not previously considered) again challenge the assumption that asymptomatic carotid disease is an important cause of stroke after cardiac surgery.
In conclusion, while the outcome data reported in this study suggest that patients undergoing synchronous carotid and cardiac revascularisation incur a low overall rate of procedural stroke, a more critical analysis suggests that the risk of stroke in cardiac surgery patients with significant asymptomatic carotid disease is extremely low. There is a desperate need for better natural history studies and an urgent need for guideline makers to review the quality of evidence underlying their current recommendations in neurologically asymptomatic patients.
